United States

Xiangxue Pharmaceutical Co Ltd (300147.SZ)

300147.SZ on Shenzhen Stock Exchange

2:28am EDT
Change (% chg)

¥0.09 (+0.67%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 300147.SZ


Xiangxue Pharmaceutical Co., Ltd. is principally engaged in the production and distribution of Chinese patent medicine. The Company provides tablets, capsules, granules, oral liquids and aerosols, among others. The Company's major products include antiviral oral liquids and indigowoad root granules. The Company distributes its... (more)


Beta: 0.86
Market Cap(Mil.): ¥9,035.77
Shares Outstanding(Mil.): 661.48
Dividend: 0.12
Yield (%): 0.82


  300147.SZ Industry Sector
P/E (TTM): 51.61 34.43 35.43
EPS (TTM): 0.26 -- --
ROI: 6.13 13.73 13.09
ROE: 6.52 14.71 14.22

BRIEF-Xiangxue Pharma plans medical investment fund, unit to invest in Chinese medicine project

* Says plans to set up medical and healthcare investment fund of size 1 billion yuan ($154.40 million) with partners

May 03 2016

BRIEF-Xiangxue Pharma to issue up to 2.5 bln yuan medium-term notes, commercial paper

* Says plans to issue up to 1 billion yuan ($153.20 million)medium-term notes, up to 1.5 billion yuan commercial paper

Feb 23 2016

BRIEF-Xiangxue Pharma's unit to invest in Chuangmei's Hong Kong stock offer

* Says Hong Kong unit signs agreement to invest HK$31 million ($4.00 million) in Chuangmei Pharmaceutical's stock offering in Hong Kong

Dec 02 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : Thomson Reuters Stock Report
Provider : Reuters Investment Profile
Provider : Wright Reports
Provider : Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.